Vendor effects on murine gut microbiota and its influence on lipopolysaccharide-induced lung inflammation and Gram-negative pneumonia

被引:14
|
作者
Wolff, Nora S. [1 ]
Jacobs, Max C. [1 ]
Haak, Bastiaan W. [1 ]
Roelofs, Joris J. T. H. [2 ]
de Vos, Alex F. [1 ]
Hugenholtz, Floor [1 ]
Wiersinga, W. Joost [1 ,3 ]
机构
[1] Univ Amsterdam, Ctr Expt & Mol Med, Amsterdam Infect & Immun Inst, Amsterdam UMC,Locat AMC, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands
[2] Univ Amsterdam, Dept Pathol, Amsterdam Cardiovasc Sci, Amsterdam UMC,Locat AMC, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands
[3] Univ Amsterdam, Dept Med, Div Infect Dis, Amsterdam UMC,Locat AMC, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands
关键词
Intestinal microbiota; Vendor; Lipopolysaccharide; Klebsiella pneumoniae; Pulmonary Inflammation; Infection; Pneumonia; Sepsis; INNATE IMMUNITY; HOST-DEFENSE;
D O I
10.1186/s40635-020-00336-w
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Background The microbiome has emerged as an important player in the pathophysiology of a whole spectrum of diseases that affect the critically ill. We hypothesized that differences in microbiota composition across vendors can influence murine models of pulmonary lipopolysaccharide (LPS) inflammation and Gram-negative pneumonia. Methods A multi-vendor approach was used with genetically similar mice derived from three different vendors (Janvier, Envigo, Charles River). This model was employed to study the effect on the host response to a pulmonary LPS challenge (1 mu gKlebsiella pneumoniaeLPS, intranasal), as well as experimentalK. pneumoniaeinfection (ATCC43816,1 x 10(4)CFU, intranasal). Results Gut microbiota analysis revealed profound intervendor differences in bacterial composition as shown by beta diversity and at various taxonomic levels. Tumor necrosis factor (TNF)-alpha and interleukin (IL)-6 release in lung and bronchoalveolar lavage fluid (BALF) were determined 6 and 24 h after intranasal treatment with LPS. No differences were found between the groups, with the exception for Envigo, showing a higher level of TNF alpha in lung and BALF at 6 h compared to Janvier and Charles River. In another set of experiments, mice from different vendors were subjected to a clinically relevant model of Gram-negative pneumonia (K. pneumoniae). At 12 and 36 h post-infection, no intervendor differences were found in bacterial dissemination, or TNF alpha and IL-6 levels in the lungs. In line, markers for organ failure did not differ between groups. Conclusions Although there was a marked variation in the gut microbiota composition of mice from different vendors, the hypothesized impact on our models of pulmonary inflammation and severe pneumonia was limited. This is of significance for experimental settings, showing that differences in gut microbiota do not have to lead to differences in outcome.
引用
收藏
页数:13
相关论文
共 30 条
  • [1] Vendor effects on murine gut microbiota and its influence on lipopolysaccharide-induced lung inflammation and Gram-negative pneumonia
    Nora S. Wolff
    Max C. Jacobs
    Bastiaan W. Haak
    Joris J. T. H. Roelofs
    Alex F. de Vos
    Floor Hugenholtz
    W. Joost Wiersinga
    Intensive Care Medicine Experimental, 8
  • [2] INFLUENCE OF LIPOPOLYSACCHARIDE-BINDING PROTEIN ON PULMONARY INFLAMMATION IN GRAM-NEGATIVE PNEUMONIA
    Taddonio, Michael A.
    Dolgachev, Vladislav
    Bosmann, Markus
    Ward, Peter A.
    Su, Grace
    Wang, Stewart C.
    Hemmila, Mark R.
    SHOCK, 2015, 43 (06): : 612 - 619
  • [3] Lipopolysaccharide structures of Gram-negative populations in the gut microbiota and effects on host interactions
    Di Lorenzo, Flaviana
    De Castro, Cristina
    Silipo, Alba
    Molinaro, Antonio
    FEMS MICROBIOLOGY REVIEWS, 2019, 43 (03) : 257 - 272
  • [4] Vendor effects on murine gut microbiota influence experimental abdominal sepsis
    Hilbert, Tobias
    Steinhagen, Folkert
    Senzig, Sebastian
    Cramer, Nina
    Bekeredjian-Ding, Isabelle
    Parcina, Marijo
    Baumgarten, Georg
    Hoeft, Andreas
    Frede, Stilla
    Boehm, Olaf
    Klaschik, Sven
    JOURNAL OF SURGICAL RESEARCH, 2017, 211 : 126 - 136
  • [5] Dysbiosis of Gram-negative gut microbiota and the associated serum lipopolysaccharide exacerbates inflammation in type 2 diabetic patients with chronic kidney disease
    Salguero, Maria V.
    Al-Obaide, Mohammed A. I.
    Singh, Ruchi
    Siepmann, Timo
    Vasylyeva, Tetyana L.
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2019, 18 (05) : 3461 - 3469
  • [6] Iron Chelation in Murine Models of Systemic Inflammation Induced by Gram-Positive and Gram-Negative Toxins
    Fokam, Danielle
    Dickson, Kayle
    Kamali, Kiyana
    Holbein, Bruce
    Colp, Patricia
    Stueck, Ashley
    Zhou, Juan
    Lehmann, Christian
    ANTIBIOTICS-BASEL, 2020, 9 (06):
  • [7] Administration of turmeric kombucha ameliorates lipopolysaccharide-induced sepsis by attenuating inflammation and modulating gut microbiota
    Su, Jingqian
    Tan, Qingqing
    Wu, Shun
    Zhou, Fen
    Xu, Chen
    Zhao, Heng
    Lin, Congfan
    Deng, Xiaohui
    Xie, Lian
    Lin, Xinrui
    Ye, Hui
    Yang, Minhe
    FRONTIERS IN MICROBIOLOGY, 2024, 15
  • [8] Effects of ethanol on cytokine production after surgery in a murine model of gram-negative pneumonia
    Spies, Claudia D.
    Lanzke, Nadine
    Schlichting, Uwe
    Muehlbauer, Steffen
    Pipolo, Carlotta
    von Mettenheim, Moritz
    Lehmann, Anett
    Morawietz, Lars
    Nattermann, Herbert
    Sander, Michael
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2008, 32 (02) : 331 - 338
  • [9] Protective effects of pravastatin in murine lipopolysaccharide-induced acute lung injury
    Yao, Hong-Wei
    Mao, Lian-Gen
    Zhu, Jian-Ping
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2006, 33 (09): : 793 - 797
  • [10] Visfatin Exerts Immunotherapeutic Effects in Lipopolysaccharide-Induced Acute Lung Injury in Murine Model
    Luo, You
    Pang, Xin-Xin
    Ansari, Abdur Rahman
    Wu, Xin-Tong
    Li, Hui-Zhen
    Zhang, Zhe-Wei
    Song, Hui
    INFLAMMATION, 2020, 43 (01) : 109 - 122